These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1540641)

  • 21. Monoamine oxidase-inhibiting properties of SR 95191, a new pyridazine derivative, in the rat: evidence for selective and reversible inhibition of monoamine oxidase type A in vivo but not in vitro.
    Kan JP; Steinberg R; Leclercq J; Worms P; Biziere K
    J Neurochem; 1988 Apr; 50(4):1137-44. PubMed ID: 3346672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of cadmium and zinc ethanolamine complexes on rat brain monoamine oxidase-B activity in vitro.
    Shaban NZ; Ali AE; Masoud MS
    J Inorg Biochem; 2003 Jun; 95(2-3):141-8. PubMed ID: 12763658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of new 2-propinylamine derivatives on mitochondrial monoamine oxidase activity].
    Shatemirova KK; Davydova GA; Verevkina IV; Tichilkin AI
    Vopr Med Khim; 1977; 23(5):609-18. PubMed ID: 595495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of rat liver monoamine oxidase by alpha-methyl- and N-propargyl-amine derivatives.
    Tipton KF; McCrodden JM; Kalir AS; Youdim MB
    Biochem Pharmacol; 1982 Apr; 31(7):1251-5. PubMed ID: 7092920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of monoamine oxidase by 3,4-dihydroxyphenylserine.
    Naoi M; Nagatsu T
    J Neurochem; 1986 Aug; 47(2):604-7. PubMed ID: 3090204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives.
    Inoue H; Castagnoli K; Van Der Schyf C; Mabic S; Igarashi K; Castagnoli N
    J Pharmacol Exp Ther; 1999 Nov; 291(2):856-64. PubMed ID: 10525109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of alpha-methylation on inactivation of monoamine oxidase by N-cyclopropylbenzylamine.
    Silverman RB
    Biochemistry; 1984 Oct; 23(22):5206-13. PubMed ID: 6509020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study of the biological pharmacology of IFO, a new selective and reversible monoamine oxidase-B inhibitor.
    Matsumoto J; Takahashi T; Agata M; Toyofuku H; Sasada N
    Jpn J Pharmacol; 1994 May; 65(1):51-7. PubMed ID: 8089930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of diethylnitrosamine on monoamine oxidase in rat liver.
    Obata T; Yamashita H; Egashira T; Yamanaka Y
    Jpn J Pharmacol; 1989 Jan; 49(1):151-3. PubMed ID: 2724679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The kinetics of monoamine oxidase inhibition by three 2-indolylmethylamine derivatives.
    Cruces MA; Elorriaga C; Fernández-Alvarez E
    Biochem Pharmacol; 1990 Aug; 40(3):535-43. PubMed ID: 2383286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism-based inhibition of monoamine oxidase by 3-aryl-Delta3-pyrrolines.
    Williams CH; Lawson J
    Biochem J; 1998 Nov; 336 ( Pt 1)(Pt 1):63-7. PubMed ID: 9806885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dramatic species differences in the susceptibility of monoamine oxidase B to a group of powerful inhibitors.
    Krueger MJ; Mazouz F; Ramsay RR; Milcent R; Singer TP
    Biochem Biophys Res Commun; 1995 Jan; 206(2):556-62. PubMed ID: 7826372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
    Severina IS; Klimova GI; Nersisian AA
    Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-[2-(o-iodophenoxy)ethyl]cyclopropylamine hydrochloride (LY121768), a potent and selective irreversible inhibitor of type A monoamine oxidase.
    Fuller RW; Hemrick-Luecke SK; Molloy BB
    Biochem Pharmacol; 1983 Apr; 32(7):1243-9. PubMed ID: 6847714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formation of the neurotransmitter glycine from the anticonvulsant milacemide is mediated by brain monoamine oxidase B.
    Janssens de Varebeke P; Cavalier R; David-Remacle M; Youdim MB
    J Neurochem; 1988 Apr; 50(4):1011-6. PubMed ID: 3346666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Steric influence on inhibition of monoamine oxidase forms by 2,3-dichloro-alpha-methylbenzylamine.
    Fuller RW; Hemrick SK
    Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):199-202. PubMed ID: 663404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of DSP-4 (N-[2-chloroethyl]-N-ethyl-2-bromobenzylamine) on monoamine oxidase activities in tissues of the rat.
    Lyles GA; Callingham BA
    J Pharm Pharmacol; 1981 Oct; 33(10):632-8. PubMed ID: 6117615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative study of catalytic properties of mink and rat liver monoamine oxidase].
    Iagodina OV
    Zh Evol Biokhim Fiziol; 2008; 44(6):570-6. PubMed ID: 19198157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different sensitivity of mitochondrial and cytosolic monoamine oxidases to in vivo but not in vitro inhibition by specific irreversible inhibitors.
    Moskvitina TA; Medvedev AE
    Med Sci Monit; 2001; 7(1):17-9. PubMed ID: 11208486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of 4-methyl-thio-phenyl-propylamine and the evaluation of its interaction with different amine oxidases.
    Gallardo-Godoy A; Hernandez M; Sanz E; Unzeta M
    Bioorg Med Chem; 2004 Jan; 12(1):273-9. PubMed ID: 14697793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.